Endometrioid adenocarcinoma arising in endometriosis foci six years after estrogen replacement therapy: a case report.
This case report describes a 53-year-old woman who developed endometrioid adenocarcinoma in endometriosis foci six years after hysterectomy, oophorectomy, and estrogen-only hormone replacement therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- Topical estrogens for the treatment of superficial dyspareunia related to genitourinary syndrome of menopause in women with a history of endometriosis: A clinical dilemma 2023
- Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature 2021
- Postmenopausal endometriosis, where are we now? 2019
- The management of menopause in women with a history of endometriosis: a systematic review 2017
- Should the ovaries be removed or retained at the time of hysterectomy for benign disease? 2009
- Hormone replacement therapy in women with past history of endometriosis 2006
- Tailoring radicality in demolitive surgery for deeply infiltrating endometriosis 2005
SciLite annotations
chemicals 1
Source provenance
- europepmc
- last seen: 2026-08-18T06:10:16.649438+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:38.158000+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00